Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Cash from Investing Activities (2017 - 2021)

Historic Cash from Investing Activities for ENDRA Life Sciences (NDRA) over the last 5 years, with Q1 2021 value amounting to -$45000.0.

  • ENDRA Life Sciences' Cash from Investing Activities fell 10134.23% to -$45000.0 in Q1 2021 from the same period last year, while for Dec 2021 it was -$45000.0, marking a year-over-year increase of 4026.52%. This contributed to the annual value of -$12796.0 for FY2024, which is 4823.83% up from last year.
  • ENDRA Life Sciences' Cash from Investing Activities amounted to -$45000.0 in Q1 2021, which was down 10134.23% from -$64850.0 recorded in Q4 2020.
  • ENDRA Life Sciences' 5-year Cash from Investing Activities high stood at $11867.0 for Q3 2020, and its period low was -$100000.0 during Q3 2018.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$22350.0 (2020), whereas its average is -$30198.9.
  • Within the past 5 years, the most significant YoY rise in ENDRA Life Sciences' Cash from Investing Activities was 6906.95% (2020), while the steepest drop was 32660.81% (2020).
  • Over the past 5 years, ENDRA Life Sciences' Cash from Investing Activities (Quarter) stood at -$7862.0 in 2017, then crashed by 1171.94% to -$100000.0 in 2018, then surged by 61.64% to -$38357.0 in 2019, then tumbled by 69.07% to -$64850.0 in 2020, then soared by 30.61% to -$45000.0 in 2021.
  • Its last three reported values are -$45000.0 in Q1 2021, -$64850.0 for Q4 2020, and $11867.0 during Q3 2020.